Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus
Clinical trial NCT02284009 · COMPLETED
Trial details
- NCT number
- NCT02284009
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-10
- Primary completion
- 2017-10-18
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.